{"transactions":[{"id":673048,"issuer":{"id":4044,"kind":"organization","name":"Relay Therapeutics, Inc.","symbol":"RLAY"},"owners":[{"id":18754,"kind":"organization","name":"SVF Pauling (Cayman) Ltd","position":1,"cik":"0001817592","reported_name":"SVF Pauling (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":18755,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M2) L.P.","position":2,"cik":"0001805808","reported_name":"SOFTBANK VISION FUND (AIV M2) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-08-28T09:01:36.000Z","date":"2026-08-25","kind":"sale","planned":false,"acquired":false,"shares":6000000,"price":19.4,"value":116400000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities held of record by SVF Pauling (Cayman) Limited, a wholly owned subsidiary of SoftBank Vision Fund (AIV M2) L.P. (\"AIV M2\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing AIV M2 in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of AIV M2, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF Pauling (Cayman) Limited's investments."}],"balance_after":21904963,"source":{"system":"sec-edgar","filing":"0001493152-26-040513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817592/000149315226040513/ownership.xml","form_type":"4"}},{"id":935446,"issuer":{"id":5363,"kind":"organization","name":"Energy Vault Holdings, Inc."},"owners":[{"id":18755,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M2) L.P.","position":1,"cik":"0001805808","reported_name":"SOFTBANK VISION FUND (AIV M2) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-01-20T21:00:03.000Z","date":"2026-01-15","kind":"sale","planned":false,"acquired":false,"shares":3000000,"price":5.65,"value":16950000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities held of record by SoftBank Vision Fund (AIV M2) L.P. (\"AIV M2\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing AIV M2 in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of AIV M2, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of AIV M2's investments"}],"balance_after":15535631,"source":{"system":"sec-edgar","filing":"0001493152-26-002946","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805808/000149315226002946/ownership.xml","form_type":"4"}},{"id":981661,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-03T16:30:19.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":191854,"price":5.9826,"value":1147785.7404,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.2794 to $5.855. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":13728924,"source":{"system":"sec-edgar","filing":"0001493152-25-025970","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225025970/ownership.xml","form_type":"4"}},{"id":985148,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T16:30:07.000Z","date":"2025-11-28","kind":"sale","planned":true,"acquired":false,"shares":61493,"price":6.44,"value":396014.92,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.3396 to $6.5398. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":13920778,"source":{"system":"sec-edgar","filing":"0001493152-25-025571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225025571/ownership.xml","form_type":"4"}},{"id":985147,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T16:30:07.000Z","date":"2025-11-26","kind":"sale","planned":true,"acquired":false,"shares":127938,"price":6.391,"value":817651.758,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.2498 to $6.50. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":13982271,"source":{"system":"sec-edgar","filing":"0001493152-25-025571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225025571/ownership.xml","form_type":"4"}},{"id":987201,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-26T16:30:21.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":235971,"price":6.38,"value":1505494.98,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.12 to $6.6094. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14110209,"source":{"system":"sec-edgar","filing":"0001493152-25-025161","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225025161/ownership.xml","form_type":"4"}},{"id":987200,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-11-26T16:30:21.000Z","date":"2025-11-24","kind":"sale","planned":true,"acquired":false,"shares":227803,"price":6.1491,"value":1400783.4273,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.93 to $6.30. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14346180,"source":{"system":"sec-edgar","filing":"0001493152-25-025161","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225025161/ownership.xml","form_type":"4"}},{"id":1011373,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-30T16:30:13.000Z","date":"2025-10-29","kind":"sale","planned":true,"acquired":false,"shares":100,"price":6.49,"value":649.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14573983,"source":{"system":"sec-edgar","filing":"0001493152-25-020240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225020240/ownership.xml","form_type":"4"}},{"id":1011372,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-30T16:30:13.000Z","date":"2025-10-28","kind":"sale","planned":true,"acquired":false,"shares":24453,"price":6.5025,"value":159005.6325,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.49 to $6.55. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14574083,"source":{"system":"sec-edgar","filing":"0001493152-25-020240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225020240/ownership.xml","form_type":"4"}},{"id":1012598,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-28T16:30:11.000Z","date":"2025-10-27","kind":"sale","planned":true,"acquired":false,"shares":66403,"price":6.0477,"value":401585.4231,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.93 to $6.18. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14598536,"source":{"system":"sec-edgar","filing":"0001493152-25-019892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225019892/ownership.xml","form_type":"4"}},{"id":1012597,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-28T16:30:11.000Z","date":"2025-10-24","kind":"sale","planned":true,"acquired":false,"shares":46696,"price":5.9595,"value":278284.812,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.92 to $6.0212. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14664939,"source":{"system":"sec-edgar","filing":"0001493152-25-019892","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225019892/ownership.xml","form_type":"4"}},{"id":1013840,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-24T16:30:12.000Z","date":"2025-10-23","kind":"sale","planned":true,"acquired":false,"shares":154383,"price":5.9898,"value":924723.2934,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.92 to $6.177. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14711635,"source":{"system":"sec-edgar","filing":"0001493152-25-019309","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225019309/ownership.xml","form_type":"4"}},{"id":1013839,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-24T16:30:12.000Z","date":"2025-10-22","kind":"sale","planned":true,"acquired":false,"shares":144266,"price":6.1529,"value":887654.2714,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.08 to $6.2552. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":14866018,"source":{"system":"sec-edgar","filing":"0001493152-25-019309","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225019309/ownership.xml","form_type":"4"}},{"id":1014749,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-22T16:30:08.000Z","date":"2025-10-21","kind":"sale","planned":true,"acquired":false,"shares":109675,"price":6.3002,"value":690974.435,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.12 to $6.4406. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15010284,"source":{"system":"sec-edgar","filing":"0001493152-25-018917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225018917/ownership.xml","form_type":"4"}},{"id":1014748,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-22T16:30:08.000Z","date":"2025-10-20","kind":"sale","planned":true,"acquired":false,"shares":220535,"price":6.1998,"value":1367272.893,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.07 to $6.2961. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15119959,"source":{"system":"sec-edgar","filing":"0001493152-25-018917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225018917/ownership.xml","form_type":"4"}},{"id":1016827,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-17T16:15:23.000Z","date":"2025-10-16","kind":"sale","planned":true,"acquired":false,"shares":12844,"price":6.1014,"value":78366.3816,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.07 to $6.1451. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15340494,"source":{"system":"sec-edgar","filing":"0001493152-25-018462","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225018462/ownership.xml","form_type":"4"}},{"id":1016826,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-17T16:15:23.000Z","date":"2025-10-15","kind":"sale","planned":true,"acquired":false,"shares":16671,"price":6.0702,"value":101196.3042,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.07 to $6.0765. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15353338,"source":{"system":"sec-edgar","filing":"0001493152-25-018462","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225018462/ownership.xml","form_type":"4"}},{"id":1019311,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-14T16:30:16.000Z","date":"2025-10-10","kind":"sale","planned":true,"acquired":false,"shares":2300,"price":6.0752,"value":13972.96,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.07 to $6.09. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15370009,"source":{"system":"sec-edgar","filing":"0001493152-25-018021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225018021/ownership.xml","form_type":"4"}},{"id":1019310,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-14T16:30:16.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":249060,"price":6.1428,"value":1529925.768,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.9625 to $6.35. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15372309,"source":{"system":"sec-edgar","filing":"0001493152-25-018021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225018021/ownership.xml","form_type":"4"}},{"id":1020845,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-09T16:30:20.000Z","date":"2025-10-08","kind":"sale","planned":true,"acquired":false,"shares":466242,"price":6.0479,"value":2819784.9918,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.6101 to $6.325. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":15621369,"source":{"system":"sec-edgar","filing":"0001493152-25-017612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225017612/ownership.xml","form_type":"4"}},{"id":1020844,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-09T16:30:20.000Z","date":"2025-10-07","kind":"sale","planned":true,"acquired":false,"shares":72133,"price":5.6029,"value":404153.9857,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.52 to $5.675. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16087611,"source":{"system":"sec-edgar","filing":"0001493152-25-017612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225017612/ownership.xml","form_type":"4"}},{"id":1022253,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-07T16:30:30.000Z","date":"2025-10-06","kind":"sale","planned":true,"acquired":false,"shares":73955,"price":5.6878,"value":420641.249,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.58 to $5.82. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments"}],"balance_after":16159744,"source":{"system":"sec-edgar","filing":"0001493152-25-017300","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225017300/ownership.xml","form_type":"4"}},{"id":1022252,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":2,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-07T16:30:30.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":450342,"price":5.5553,"value":2501784.9126,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.355 to $5.823. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments"}],"balance_after":16233699,"source":{"system":"sec-edgar","filing":"0001493152-25-017300","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315225017300/ownership.xml","form_type":"4"}},{"id":1057899,"issuer":{"id":3157,"kind":"organization","name":"Coupang, Inc.","symbol":"CPNG"},"owners":[{"id":76193,"kind":"organization","name":"SVF Investments (UK) Ltd","position":1,"cik":"0001716729","reported_name":"SVF Investments (UK) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-08-23T01:00:04.000Z","date":"2025-08-20","kind":"sale","planned":false,"acquired":false,"shares":20000000,"price":28,"value":560000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Investments (UK) Limited (\"SVF Investments\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") of SVF Investments, is exclusively responsible for managing SVF Investments in accordance with the Alternative Investment Fund Managers Directive, and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF Investments, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, and disposal of the investments held by SVF Investments."}],"balance_after":289542259,"source":{"system":"sec-edgar","filing":"0001641172-25-025311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731509/000164117225025311/ownership.xml","form_type":"4"}},{"id":1108045,"issuer":{"id":3157,"kind":"organization","name":"Coupang, Inc.","symbol":"CPNG"},"owners":[{"id":76193,"kind":"organization","name":"SVF Investments (UK) Ltd","position":1,"cik":"0001716729","reported_name":"SVF Investments (UK) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-18T01:00:05.000Z","date":"2025-06-13","kind":"sale","planned":false,"acquired":false,"shares":10000000,"price":28.25,"value":282500000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Investments (UK) Limited (\"SVF Investments\"). SB Investment Advisors (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") of SVF Investments, is exclusively responsible for managing SVF Investments in accordance with the Alternative Investment Fund Managers Directive, and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF Investments, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, and disposal of the investments held by SVF Investments."}],"balance_after":309542259,"source":{"system":"sec-edgar","filing":"0001641172-25-015491","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731509/000164117225015491/ownership.xml","form_type":"4"}},{"id":1152233,"issuer":{"id":3157,"kind":"organization","name":"Coupang, Inc.","symbol":"CPNG"},"owners":[{"id":76193,"kind":"organization","name":"SVF Investments (UK) Ltd","position":1,"cik":"0001716729","reported_name":"SVF Investments (UK) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-05-13T01:00:07.000Z","date":"2025-05-08","kind":"sale","planned":false,"acquired":false,"shares":30000000,"price":25.75,"value":772500000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Investments (UK) Limited (\"SVF Investments\"). SB Investment Advisors (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") of SVF Investments, is exclusively responsible for managing SVF Investments in accordance with the Alternative Investment Fund Managers Directive, and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF Investments, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, and disposal of the investments held by SVF Investments."}],"balance_after":319542259,"source":{"system":"sec-edgar","filing":"0001641172-25-009791","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731509/000164117225009791/ownership.xml","form_type":"4"}},{"id":1190986,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2025-03-26T21:00:04.000Z","date":"2025-03-24","kind":"sale","planned":false,"acquired":false,"shares":10000000,"price":9.15,"value":91500000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":48070273,"source":{"system":"sec-edgar","filing":"0001641172-25-000811","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000164117225000811/ownership.xml","form_type":"4"}},{"id":1325469,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-12-19T21:00:04.000Z","date":"2024-12-17","kind":"sale","planned":false,"acquired":false,"shares":10000000,"price":6.33,"value":63300000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":58070273,"source":{"system":"sec-edgar","filing":"0001493152-24-050856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315224050856/ownership.xml","form_type":"4"}},{"id":1405237,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-09-17T21:00:05.000Z","date":"2024-09-13","kind":"sale","planned":false,"acquired":false,"shares":7500000,"price":6.24,"value":46800000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":68070273,"source":{"system":"sec-edgar","filing":"0001493152-24-036915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315224036915/ownership.xml","form_type":"4"}},{"id":1509058,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-05-20T21:00:14.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":16900000,"price":4.3,"value":72670000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":75570273,"source":{"system":"sec-edgar","filing":"0001493152-24-020806","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315224020806/ownership.xml","form_type":"4"}},{"id":1576772,"issuer":{"id":3157,"kind":"organization","name":"Coupang, Inc.","symbol":"CPNG"},"owners":[{"id":76193,"kind":"organization","name":"SVF Investments (UK) Ltd","position":1,"cik":"0001716729","reported_name":"SVF Investments (UK) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-03-15T01:00:11.000Z","date":"2024-03-13","kind":"sale","planned":false,"acquired":false,"shares":15000000,"price":19.6,"value":294000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.60 to $19.655. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Investments (UK) Limited (\"SVF Investments\"). SB Investment Advisors (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") of SVF Investments, is exclusively responsible for managing SVF Investments in accordance with the Alternative Investment Fund Managers Directive, and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF Investments, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, and disposal of the investments held by SVF Investments."}],"balance_after":349542259,"source":{"system":"sec-edgar","filing":"0001493152-24-009998","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731509/000149315224009998/ownership.xml","form_type":"4"}},{"id":1576771,"issuer":{"id":3157,"kind":"organization","name":"Coupang, Inc.","symbol":"CPNG"},"owners":[{"id":76193,"kind":"organization","name":"SVF Investments (UK) Ltd","position":1,"cik":"0001716729","reported_name":"SVF Investments (UK) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-03-15T01:00:11.000Z","date":"2024-03-12","kind":"sale","planned":false,"acquired":false,"shares":524708,"price":19.4922,"value":10227713.2776,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.39 to $19.6997. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Investments (UK) Limited (\"SVF Investments\"). SB Investment Advisors (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") of SVF Investments, is exclusively responsible for managing SVF Investments in accordance with the Alternative Investment Fund Managers Directive, and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF Investments, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, and disposal of the investments held by SVF Investments."}],"balance_after":364542259,"source":{"system":"sec-edgar","filing":"0001493152-24-009998","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731509/000149315224009998/ownership.xml","form_type":"4"}},{"id":1576770,"issuer":{"id":3157,"kind":"organization","name":"Coupang, Inc.","symbol":"CPNG"},"owners":[{"id":76193,"kind":"organization","name":"SVF Investments (UK) Ltd","position":1,"cik":"0001716729","reported_name":"SVF Investments (UK) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-03-15T01:00:11.000Z","date":"2024-03-12","kind":"sale","planned":false,"acquired":false,"shares":31089446,"price":19,"value":590699474.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Investments (UK) Limited (\"SVF Investments\"). SB Investment Advisors (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") of SVF Investments, is exclusively responsible for managing SVF Investments in accordance with the Alternative Investment Fund Managers Directive, and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF Investments, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, and disposal of the investments held by SVF Investments."}],"balance_after":365066967,"source":{"system":"sec-edgar","filing":"0001493152-24-009998","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731509/000149315224009998/ownership.xml","form_type":"4"}},{"id":1680808,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2024-01-11T21:00:11.000Z","date":"2024-01-09","kind":"sale","planned":false,"acquired":false,"shares":10000000,"price":3.66,"value":36600000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":92470273,"source":{"system":"sec-edgar","filing":"0001493152-24-002111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315224002111/ownership.xml","form_type":"4"}},{"id":1707381,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-12-18T21:00:34.000Z","date":"2023-12-14","kind":"sale","planned":false,"acquired":false,"shares":14895000,"price":2.66,"value":39620700.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":102470273,"source":{"system":"sec-edgar","filing":"0001493152-23-045325","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000149315223045325/ownership.xml","form_type":"4"}},{"id":1725543,"issuer":{"id":3157,"kind":"organization","name":"Coupang, Inc.","symbol":"CPNG"},"owners":[{"id":76193,"kind":"organization","name":"SVF Investments (UK) Ltd","position":1,"cik":"0001716729","reported_name":"SVF Investments (UK) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-12-02T02:00:26.000Z","date":"2023-11-29","kind":"sale","planned":false,"acquired":false,"shares":30000000,"price":15.39,"value":461700000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Investments (UK) Limited (\"SVF Investments\"). SB Investment Advisors (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") of SVF Investments, is exclusively responsible for managing SVF Investments in accordance with the Alternative Investment Fund Managers Directive, and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF Investments, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, and disposal of the investments held by SVF Investments."}],"balance_after":396156413,"source":{"system":"sec-edgar","filing":"0001493152-23-043471","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731509/000149315223043471/ownership.xml","form_type":"4"}},{"id":1770501,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":76193,"kind":"organization","name":"SVF Investments (UK) Ltd","position":1,"cik":"0001716729","reported_name":"SVF Investments (UK) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109311,"kind":"organization","name":"SVF Holdings (UK) LLP","position":2,"cik":"0001716727","reported_name":"SVF Holdings (UK) LLP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109312,"kind":"organization","name":"SoftBank Vision Fund L.P.","position":3,"cik":"0001699940","reported_name":"SoftBank Vision Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2023-10-03T01:00:08.000Z","date":"2023-09-28","kind":"sale","planned":false,"acquired":false,"shares":10000000,"price":12.6,"value":126000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities held of record by SVF Investments (UK) Limited (\"SVF Investments\"). Softbank Vision Fund L.P. is the managing member of SVF Holdings (UK) LLP, which is the sole owner of SVF Investments. SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as the alternative investment fund manager (\"AIFM\") of SoftBank Vision Fund L.P. SBIA UK is authorized and regulated by the UK Financial Conduct Authority and is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund L.P.'s investments."}],"balance_after":73031667,"source":{"system":"sec-edgar","filing":"0000950170-23-051247","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731509/000095017023051247/ownership.xml","form_type":"4"}},{"id":1836504,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T21:00:10.000Z","date":"2023-06-30","kind":"sale","planned":false,"acquired":false,"shares":700,"price":25.11,"value":17577.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16684041,"source":{"system":"sec-edgar","filing":"0000899243-23-017010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323017010/doc4.xml","form_type":"4"}},{"id":1841152,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-30T21:00:09.000Z","date":"2023-06-29","kind":"sale","planned":false,"acquired":false,"shares":89942,"price":25.1799,"value":2264730.5658,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.37. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16684741,"source":{"system":"sec-edgar","filing":"0000899243-23-016775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016775/doc4.xml","form_type":"4"}},{"id":1841151,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-30T21:00:09.000Z","date":"2023-06-28","kind":"sale","planned":false,"acquired":false,"shares":7010,"price":25.0958,"value":175921.558,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.15. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16774683,"source":{"system":"sec-edgar","filing":"0000899243-23-016775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016775/doc4.xml","form_type":"4"}},{"id":1846600,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-22T21:00:13.000Z","date":"2023-06-20","kind":"sale","planned":false,"acquired":false,"shares":9902,"price":25.1769,"value":249301.6638,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.16 to $25.2603. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16781693,"source":{"system":"sec-edgar","filing":"0000899243-23-016308","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016308/doc4.xml","form_type":"4"}},{"id":1849670,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T21:00:11.000Z","date":"2023-06-16","kind":"sale","planned":false,"acquired":false,"shares":17037,"price":26.1304,"value":445183.6248,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.13 to $26.16. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16791595,"source":{"system":"sec-edgar","filing":"0000899243-23-016075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016075/doc4.xml","form_type":"4"}},{"id":1849669,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T21:00:11.000Z","date":"2023-06-16","kind":"sale","planned":false,"acquired":false,"shares":111107,"price":25.3251,"value":2813795.8857,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.16 to $25.9131. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16808632,"source":{"system":"sec-edgar","filing":"0000899243-23-016075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016075/doc4.xml","form_type":"4"}},{"id":1849668,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T21:00:11.000Z","date":"2023-06-15","kind":"sale","planned":false,"acquired":false,"shares":2417,"price":26.0195,"value":62889.1315,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.04. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16919739,"source":{"system":"sec-edgar","filing":"0000899243-23-016075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016075/doc4.xml","form_type":"4"}},{"id":1849667,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T21:00:11.000Z","date":"2023-06-15","kind":"sale","planned":false,"acquired":false,"shares":52765,"price":25.8465,"value":1363790.5725,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.585 to $25.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16922156,"source":{"system":"sec-edgar","filing":"0000899243-23-016075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323016075/doc4.xml","form_type":"4"}},{"id":1854486,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T21:00:11.000Z","date":"2023-06-14","kind":"sale","planned":false,"acquired":false,"shares":36281,"price":26.2431,"value":952125.9111,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.6587. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":16974921,"source":{"system":"sec-edgar","filing":"0000899243-23-015663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323015663/doc4.xml","form_type":"4"}},{"id":1854485,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T21:00:11.000Z","date":"2023-06-14","kind":"sale","planned":false,"acquired":false,"shares":20967,"price":25.9213,"value":543491.8971,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.77 to $25.9999. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17011202,"source":{"system":"sec-edgar","filing":"0000899243-23-015663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323015663/doc4.xml","form_type":"4"}},{"id":1854484,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T21:00:11.000Z","date":"2023-06-13","kind":"sale","planned":false,"acquired":false,"shares":70307,"price":27.2307,"value":1914508.8249,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.49. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17032169,"source":{"system":"sec-edgar","filing":"0000899243-23-015663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323015663/doc4.xml","form_type":"4"}},{"id":1854483,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T21:00:11.000Z","date":"2023-06-13","kind":"sale","planned":false,"acquired":false,"shares":36547,"price":26.8058,"value":979671.5726,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.6169 to $26.9997. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17102476,"source":{"system":"sec-edgar","filing":"0000899243-23-015663","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323015663/doc4.xml","form_type":"4"}},{"id":1860728,"issuer":{"id":3646,"kind":"organization","name":"Compass, Inc.","symbol":"COMP"},"owners":[{"id":81523,"kind":"organization","name":"SVF Excalibur (Cayman) Ltd","position":1,"cik":"0001836869","reported_name":"SVF Excalibur (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":2,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":3,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":4,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-09T21:00:08.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":15000000,"price":3.69,"value":55350000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held of record by SVF Excalibur (Cayman) Limited, which is a wholly owned subsidiary of SVF Endurance (Cayman) Limited, which is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. SB Investment Advisers (UK) Limited has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SoftBank Vision Fund (AIV M1) L.P. in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As AIFM of SoftBank Vision Fund (AIV M1) L.P., SB Investment Advisers (UK) Limited is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund (AIV M1) L.P.'s investments. As a result, each of the reporting persons may be deemed to share beneficial ownership of the securities reported herein. Each of them disclaims any such beneficial ownership except to the extent of its pecuniary interest therein."}],"balance_after":117365273,"source":{"system":"sec-edgar","filing":"0000899243-23-015323","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323015323/doc4.xml","form_type":"4"}},{"id":1865258,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T21:00:10.000Z","date":"2023-06-05","kind":"sale","planned":false,"acquired":false,"shares":5197,"price":27.3231,"value":141998.1507,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.29 to $27.37. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17139023,"source":{"system":"sec-edgar","filing":"0000899243-23-014628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323014628/doc4.xml","form_type":"4"}},{"id":1865257,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T21:00:10.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":34365,"price":27.3165,"value":938731.5225,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.29 to $27.36. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17144220,"source":{"system":"sec-edgar","filing":"0000899243-23-014628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323014628/doc4.xml","form_type":"4"}},{"id":1878228,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:13.000Z","date":"2023-05-24","kind":"sale","planned":false,"acquired":false,"shares":2323,"price":27.1155,"value":62989.3065,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.24. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17178585,"source":{"system":"sec-edgar","filing":"0000899243-23-013936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013936/doc4.xml","form_type":"4"}},{"id":1878227,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:13.000Z","date":"2023-05-24","kind":"sale","planned":false,"acquired":false,"shares":66754,"price":26.2527,"value":1752472.7358,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17180908,"source":{"system":"sec-edgar","filing":"0000899243-23-013936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013936/doc4.xml","form_type":"4"}},{"id":1878226,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:13.000Z","date":"2023-05-24","kind":"sale","planned":false,"acquired":false,"shares":35307,"price":25.8911,"value":914137.0677,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.77 to $25.9988. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17247662,"source":{"system":"sec-edgar","filing":"0000899243-23-013936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013936/doc4.xml","form_type":"4"}},{"id":1878225,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:13.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":23348,"price":27.0159,"value":630767.2332,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.045. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17282969,"source":{"system":"sec-edgar","filing":"0000899243-23-013936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013936/doc4.xml","form_type":"4"}},{"id":1878224,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:13.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":144402,"price":26.6104,"value":3842594.9808,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.9999. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17306317,"source":{"system":"sec-edgar","filing":"0000899243-23-013936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013936/doc4.xml","form_type":"4"}},{"id":1878223,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-25T21:00:13.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":2317,"price":25.8385,"value":59867.8045,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.73 to $25.9992. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17450719,"source":{"system":"sec-edgar","filing":"0000899243-23-013936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013936/doc4.xml","form_type":"4"}},{"id":1881190,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:00:09.000Z","date":"2023-05-22","kind":"sale","planned":false,"acquired":false,"shares":91896,"price":25.7237,"value":2363905.1352,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.37 to $25.91. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17453036,"source":{"system":"sec-edgar","filing":"0000899243-23-013759","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013759/doc4.xml","form_type":"4"}},{"id":1881189,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-23T21:00:09.000Z","date":"2023-05-19","kind":"sale","planned":false,"acquired":false,"shares":91651,"price":25.3814,"value":2326230.6914,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.15 to $25.72. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17544932,"source":{"system":"sec-edgar","filing":"0000899243-23-013759","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323013759/doc4.xml","form_type":"4"}},{"id":1899629,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-09T21:00:13.000Z","date":"2023-05-05","kind":"sale","planned":false,"acquired":false,"shares":136,"price":25.1032,"value":3414.0352,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.09 to $25.14. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17636583,"source":{"system":"sec-edgar","filing":"0000899243-23-012478","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323012478/doc4.xml","form_type":"4"}},{"id":1902935,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-05T21:00:15.000Z","date":"2023-05-04","kind":"sale","planned":false,"acquired":false,"shares":114332,"price":25.5498,"value":2921159.7336,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.76. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17636719,"source":{"system":"sec-edgar","filing":"0000899243-23-012410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323012410/doc4.xml","form_type":"4"}},{"id":1902934,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-05T21:00:15.000Z","date":"2023-05-03","kind":"sale","planned":false,"acquired":false,"shares":83674,"price":25.512,"value":2134691.088,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.29 to $25.95. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17751051,"source":{"system":"sec-edgar","filing":"0000899243-23-012410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323012410/doc4.xml","form_type":"4"}},{"id":1906241,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-03T21:00:07.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":3075,"price":25.3047,"value":77811.9525,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.28 to $25.35. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17834725,"source":{"system":"sec-edgar","filing":"0000899243-23-012176","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323012176/doc4.xml","form_type":"4"}},{"id":1913382,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-26T21:00:12.000Z","date":"2023-04-25","kind":"sale","planned":false,"acquired":false,"shares":961,"price":25.2999,"value":24313.2039,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.28 to $25.3692. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17837800,"source":{"system":"sec-edgar","filing":"0000899243-23-011791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011791/doc4.xml","form_type":"4"}},{"id":1913381,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-26T21:00:12.000Z","date":"2023-04-24","kind":"sale","planned":false,"acquired":false,"shares":66038,"price":25.4192,"value":1678633.1296,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.28 to $25.88. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17838761,"source":{"system":"sec-edgar","filing":"0000899243-23-011791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011791/doc4.xml","form_type":"4"}},{"id":1914945,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-24T21:00:08.000Z","date":"2023-04-21","kind":"sale","planned":false,"acquired":false,"shares":15908,"price":26.0091,"value":413752.7628,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.14. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17904799,"source":{"system":"sec-edgar","filing":"0000899243-23-011617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011617/doc4.xml","form_type":"4"}},{"id":1914944,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-24T21:00:08.000Z","date":"2023-04-21","kind":"sale","planned":false,"acquired":false,"shares":289485,"price":25.7647,"value":7458494.1795,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.28 to $25.9999. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":17920707,"source":{"system":"sec-edgar","filing":"0000899243-23-011617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011617/doc4.xml","form_type":"4"}},{"id":1914943,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-24T21:00:08.000Z","date":"2023-04-20","kind":"sale","planned":false,"acquired":false,"shares":6590,"price":25.0603,"value":165147.377,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.07. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18210192,"source":{"system":"sec-edgar","filing":"0000899243-23-011617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011617/doc4.xml","form_type":"4"}},{"id":1916512,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-20T21:00:09.000Z","date":"2023-04-19","kind":"sale","planned":false,"acquired":false,"shares":76114,"price":25.1198,"value":1911968.4572,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.24. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18216782,"source":{"system":"sec-edgar","filing":"0000899243-23-011512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011512/doc4.xml","form_type":"4"}},{"id":1916511,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-20T21:00:09.000Z","date":"2023-04-18","kind":"sale","planned":false,"acquired":false,"shares":6953,"price":25.1203,"value":174661.4459,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.2624. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18292896,"source":{"system":"sec-edgar","filing":"0000899243-23-011512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011512/doc4.xml","form_type":"4"}},{"id":1918186,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-18T21:00:06.000Z","date":"2023-04-17","kind":"sale","planned":false,"acquired":false,"shares":10524,"price":25.0609,"value":263740.9116,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.08. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18299849,"source":{"system":"sec-edgar","filing":"0000899243-23-011414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011414/doc4.xml","form_type":"4"}},{"id":1918185,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-18T21:00:06.000Z","date":"2023-04-14","kind":"sale","planned":false,"acquired":false,"shares":9565,"price":25.1074,"value":240152.281,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.189. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18310373,"source":{"system":"sec-edgar","filing":"0000899243-23-011414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323011414/doc4.xml","form_type":"4"}},{"id":1941745,"issuer":{"id":3185,"kind":"organization","name":"Roivant Sciences Ltd.","symbol":"ROIV"},"owners":[{"id":76193,"kind":"organization","name":"SVF Investments (UK) Ltd","position":1,"cik":"0001716729","reported_name":"SVF Investments (UK) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109312,"kind":"organization","name":"SoftBank Vision Fund L.P.","position":2,"cik":"0001699940","reported_name":"SoftBank Vision Fund L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109311,"kind":"organization","name":"SVF Holdings (UK) LLP","position":3,"cik":"0001716727","reported_name":"SVF Holdings (UK) LLP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":4,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2023-03-23T01:00:07.000Z","date":"2023-03-20","kind":"sale","planned":false,"acquired":false,"shares":12000000,"price":8,"value":96000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities held of record by SVF Investments (UK) Limited (\"SVF Investments\"). Softbank Vision Fund L.P. is the managing member of SVF Holdings (UK) LLP, which is the sole owner of SVF Investments. SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as the alternative investment fund manager (\"AIFM\") of SoftBank Vision Fund L.P. SBIA UK is authorized and regulated by the UK Financial Conduct Authority and is exclusively responsible for making all decisions related to the acquisition, structuring, financing and disposal of SoftBank Vision Fund L.P.'s investments."}],"balance_after":83031667,"source":{"system":"sec-edgar","filing":"0000899243-23-009465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731509/000089924323009465/doc4.xml","form_type":"4"}},{"id":1996113,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-23T21:00:24.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":2925,"price":29.0755,"value":85045.8375,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.0067 to $29.1558. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18319938,"source":{"system":"sec-edgar","filing":"0000899243-23-006057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323006057/doc4.xml","form_type":"4"}},{"id":1996112,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-23T21:00:24.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":63946,"price":28.5137,"value":1823337.0602,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.0053 to $28.9976. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18322863,"source":{"system":"sec-edgar","filing":"0000899243-23-006057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323006057/doc4.xml","form_type":"4"}},{"id":1996111,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-23T21:00:24.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":7364,"price":27.4893,"value":202431.2052,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.02 to $27.9986. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18386809,"source":{"system":"sec-edgar","filing":"0000899243-23-006057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323006057/doc4.xml","form_type":"4"}},{"id":1996110,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-23T21:00:24.000Z","date":"2023-02-21","kind":"sale","acquired":false,"shares":242,"price":26.95,"value":6521.9,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18394173,"source":{"system":"sec-edgar","filing":"0000899243-23-006057","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323006057/doc4.xml","form_type":"4"}},{"id":2007855,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-17T21:00:19.000Z","date":"2023-02-15","kind":"sale","acquired":false,"shares":38964,"price":26.7525,"value":1042384.41,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.72 to $26.86. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18394415,"source":{"system":"sec-edgar","filing":"0000899243-23-005577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323005577/doc4.xml","form_type":"4"}},{"id":2013709,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-15T21:00:22.000Z","date":"2023-02-14","kind":"sale","acquired":false,"shares":38907,"price":26.8103,"value":1043108.3421,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.72 to $26.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18433379,"source":{"system":"sec-edgar","filing":"0000899243-23-005183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323005183/doc4.xml","form_type":"4"}},{"id":2013708,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-15T21:00:22.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":52250,"price":26.1401,"value":1365820.225,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.29. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18472286,"source":{"system":"sec-edgar","filing":"0000899243-23-005183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323005183/doc4.xml","form_type":"4"}},{"id":2013707,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-15T21:00:22.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":26800,"price":25.7748,"value":690764.64,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.31 to $25.995. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18524536,"source":{"system":"sec-edgar","filing":"0000899243-23-005183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323005183/doc4.xml","form_type":"4"}},{"id":2020140,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-13T21:00:29.000Z","date":"2023-02-10","kind":"sale","acquired":false,"shares":84408,"price":26.1586,"value":2207995.1088,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.39. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18551336,"source":{"system":"sec-edgar","filing":"0000899243-23-004850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004850/doc4.xml","form_type":"4"}},{"id":2020139,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-13T21:00:29.000Z","date":"2023-02-10","kind":"sale","acquired":false,"shares":12813,"price":25.935,"value":332305.155,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.76 to $25.9985. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18635744,"source":{"system":"sec-edgar","filing":"0000899243-23-004850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004850/doc4.xml","form_type":"4"}},{"id":2020138,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-13T21:00:29.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":9490,"price":27.1713,"value":257855.637,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.31. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18648557,"source":{"system":"sec-edgar","filing":"0000899243-23-004850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004850/doc4.xml","form_type":"4"}},{"id":2020137,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-13T21:00:29.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":127016,"price":26.3253,"value":3343734.3048,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18658047,"source":{"system":"sec-edgar","filing":"0000899243-23-004850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004850/doc4.xml","form_type":"4"}},{"id":2020136,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-13T21:00:29.000Z","date":"2023-02-09","kind":"sale","acquired":false,"shares":544,"price":25.9904,"value":14138.7776,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.99 to $25.9955. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18785063,"source":{"system":"sec-edgar","filing":"0000899243-23-004850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004850/doc4.xml","form_type":"4"}},{"id":2024872,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:00:19.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":1300,"price":29,"value":37700.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18785607,"source":{"system":"sec-edgar","filing":"0000899243-23-004510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004510/doc4.xml","form_type":"4"}},{"id":2024871,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:00:19.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":44498,"price":28.313,"value":1259871.874,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.90. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18786907,"source":{"system":"sec-edgar","filing":"0000899243-23-004510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004510/doc4.xml","form_type":"4"}},{"id":2024870,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:00:19.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":36116,"price":27.317,"value":986580.772,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.04 to $27.9951. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18831405,"source":{"system":"sec-edgar","filing":"0000899243-23-004510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004510/doc4.xml","form_type":"4"}},{"id":2024869,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:00:19.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":59066,"price":29.3559,"value":1733935.5894,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18867521,"source":{"system":"sec-edgar","filing":"0000899243-23-004510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004510/doc4.xml","form_type":"4"}},{"id":2024868,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T21:00:19.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":4442,"price":28.9195,"value":128460.419,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.85 to $28.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18926587,"source":{"system":"sec-edgar","filing":"0000899243-23-004510","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004510/doc4.xml","form_type":"4"}},{"id":2028619,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T21:00:11.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":14752,"price":30.0942,"value":443949.6384,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.24. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18931029,"source":{"system":"sec-edgar","filing":"0000899243-23-004262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004262/doc4.xml","form_type":"4"}},{"id":2028618,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T21:00:11.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":30497,"price":29.8357,"value":909899.3429,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.51 to $29.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18945781,"source":{"system":"sec-edgar","filing":"0000899243-23-004262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004262/doc4.xml","form_type":"4"}},{"id":2028617,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T21:00:11.000Z","date":"2023-02-03","kind":"sale","acquired":false,"shares":62468,"price":30.4561,"value":1902531.6548,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.085 to $30.94. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":18976278,"source":{"system":"sec-edgar","filing":"0000899243-23-004262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004262/doc4.xml","form_type":"4"}},{"id":2028616,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-07T21:00:11.000Z","date":"2023-02-03","kind":"sale","acquired":false,"shares":6318,"price":29.8517,"value":188603.0406,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.35 to $29.98. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19038746,"source":{"system":"sec-edgar","filing":"0000899243-23-004262","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323004262/doc4.xml","form_type":"4"}},{"id":2033186,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T21:00:13.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":86801,"price":29.7003,"value":2578015.7403,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.15 to $29.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19045064,"source":{"system":"sec-edgar","filing":"0000899243-23-003957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323003957/doc4.xml","form_type":"4"}},{"id":2033185,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T21:00:13.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":35173,"price":29.1948,"value":1026868.7004,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.52. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19131865,"source":{"system":"sec-edgar","filing":"0000899243-23-003957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323003957/doc4.xml","form_type":"4"}},{"id":2033184,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-03T21:00:13.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":26661,"price":28.7795,"value":767290.2495,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.5431 to $28.9958. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19167038,"source":{"system":"sec-edgar","filing":"0000899243-23-003957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323003957/doc4.xml","form_type":"4"}},{"id":2038602,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":72278,"kind":"organization","name":"SVF Endurance (Cayman) Ltd","position":1,"cik":"0001782338","reported_name":"SVF Endurance (Cayman) Ltd","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":15722,"kind":"organization","name":"SB INVESTMENT ADVISERS (UK) LTD","position":2,"cik":"0001731509","reported_name":"SB INVESTMENT ADVISERS (UK) LTD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72279,"kind":"organization","name":"SOFTBANK VISION FUND (AIV M1) L.P.","position":3,"cik":"0001755143","reported_name":"SOFTBANK VISION FUND (AIV M1) L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-02-01T21:00:11.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":70567,"price":29.4965,"value":2081479.5155,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.77. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. (\"SVF\"). SB Investment Advisers (UK) Limited (\"SBIA UK\") has been appointed as alternative investment fund manager (\"AIFM\") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments."}],"balance_after":19193699,"source":{"system":"sec-edgar","filing":"0000899243-23-003181","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782338/000089924323003181/doc4.xml","form_type":"4"}}],"next_cursor":"2023-02-01T21:00:11.000000Z,2038602"}